Overall Technical outlook

Price Summary

In today's trading, NATCO Pharma Limited's stock increased by 3.2%, showcasing an outstanding market day.
NATCO Pharma Limited's stock opened at 810.0 on 2026-01-30, surged to a high of 841.3, hit a low of 806.05, and closed up 3.2% at 835.9, with 565233 shares traded.
The stock's peak price over the last 52 weeks is 1328.0, with the lowest being 746.5.
Analysts' predictions indicate that NATCOPHARM's future price will be between 712.0 and 1480.0, with a mean price expectation of approximately 970.36365.

Technicals

Support and Resistance: At 835.9, the price is held up by support at 795.55 and faces resistance at 841.25 for NATCOPHARM. This suggests a trading range where 795.55 provides a base and 841.25 limits upward movement.
NATCOPHARM supportResistance 2040c2
Support/Resistance for NATCOPHARM


Aroon: The Aroon indicator shows a continuation of the bearish trend, with Aroon Down holding steady at the 100 level. This ongoing downward pressure requires further exploration with additional indicators to understand its broader implications.
NATCOPHARM aroon 2040c2
Aroon chart for NATCO Pharma Limited


Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
NATCOPHARM bbands 2040c2
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR continues its bearish trend for NATCO Pharma Limited, setting a resistance level that could hinder upward momentum. This resistance suggests that the market may face challenges in breaking higher, reflecting persistent bearish sentiment.
NATCOPHARM psar 2040c2
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: With the K-line positioned above the D-line and under 20 on the stochastic indicator, the market may be entering a bullish phase. This pattern indicates that the market could be preparing for an upward trend, emerging from a lower level. Investors might interpret this as a signal of potential growth for NATCO Pharma Limited.
NATCOPHARM stoch 2040c2
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
NATCOPHARM trippleSMA 2040c2
Tripple SMA chart for NATCO Pharma Limited


Before diving into the technical aspects of a company, such as stock price charts or volume trends, it's important to understand its fundamentals. These fundamentals include financial stability, growth potential, and strategic positioning. Additionally, knowing the broader industry landscape, including competitive pressures and regulatory factors, offers deeper insights. When this fundamental analysis is combined with technical indicators, it leads to more informed, accurate evaluations of the company's overall performance.